NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells
The enzyme responsible for the synthesis of nitric oxide (NO) from L-arginine in mammalian tissues is known as nitric oxide synthase (NOS) (EC.1.14.13.39). In the present study, the role of NO in the regulation of exocrine secretion was investigated in rat pancreatic acinar cells. Treatment of rat p...
Gespeichert in:
Veröffentlicht in: | Archives of pharmacal research 1998-12, Vol.21 (6), p.657-663 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 663 |
---|---|
container_issue | 6 |
container_start_page | 657 |
container_title | Archives of pharmacal research |
container_volume | 21 |
creator | Ahn, S H Seo, D W Ko, Y K Sung, D S Bae, G U Yoon, J W Hong, S Y Han, J W Lee, H W |
description | The enzyme responsible for the synthesis of nitric oxide (NO) from L-arginine in mammalian tissues is known as nitric oxide synthase (NOS) (EC.1.14.13.39). In the present study, the role of NO in the regulation of exocrine secretion was investigated in rat pancreatic acinar cells. Treatment of rat pancreatic acinar cells with cholecystokinin-octapeptide (CCK-OP) resulted in an increase in the arginine conversion to citrulline, the amount of NOx, the release of amylase, and the level of cGMP. Especially, CCK-OP-stimulated increase of arginine to citrulline transformation, the amount of NOx and cGMP level were completely counteracted by the inhibitor of NOS, NG-monomethyl-L-arginine (MMA), by contrast, that of amylase release was partially reduced. Furthermore, MMA-induced decrease of NOS activity and amylase release showed dose-dependent pattern. The data on the time course of CCK-OP-induced citrulline formation and cGMP rise indicate that NOS and guanylate cyclase were activated by treatment of CCK-OP. However, the mechanism of agonist-stimulated guanylate cyclase activation in acinar cells remains unknown. Therefore, activation of NOS is one of the early events in receptor-mediated cascade of reactions in pancreatic acinar cells and NO, not completely, but partially mediate pancreatic enzyme exocrine secretion. |
doi_str_mv | 10.1007/BF02976753 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69097165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69097165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-f00b11c0fd6c452000fc552bace7583b75101f9b643590f17a62e6ac9dc899923</originalsourceid><addsrcrecordid>eNpFkEFLAzEQRoMotVYv3oWcPAhrJ0mTbI5abBXUiuh5yWYTjOxuarKt9t-7pUVP8zG8-RgeQucErgmAHN_OgCopJGcHaEj6lDGZi0M0BMpZJqhQx-gkpU8AJjjnAzRQucg5Y0P0-rwYm_nTC17q7uNbb7BP2LfrUK9t1Qdsf4KJvrU4WRNt50OLXQwNjrrrT9p-pztvsDa-1REbW9fpFB05XSd7tp8j9D67e5veZ4-L-cP05jEzNKdd5gBKQgy4SpgJpwDgDOe01MZKnrNScgLEqVJMGFfgiNSCWqGNqkyulKJshC53vcsYvlY2dUXj0_YD3dqwSoVQoCQRvAevdqCJIaVoXbGMvtFxUxAotgKLf4E9fLFvXZWNrf7QvTH2C_vqagk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69097165</pqid></control><display><type>article</type><title>NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Ahn, S H ; Seo, D W ; Ko, Y K ; Sung, D S ; Bae, G U ; Yoon, J W ; Hong, S Y ; Han, J W ; Lee, H W</creator><creatorcontrib>Ahn, S H ; Seo, D W ; Ko, Y K ; Sung, D S ; Bae, G U ; Yoon, J W ; Hong, S Y ; Han, J W ; Lee, H W</creatorcontrib><description>The enzyme responsible for the synthesis of nitric oxide (NO) from L-arginine in mammalian tissues is known as nitric oxide synthase (NOS) (EC.1.14.13.39). In the present study, the role of NO in the regulation of exocrine secretion was investigated in rat pancreatic acinar cells. Treatment of rat pancreatic acinar cells with cholecystokinin-octapeptide (CCK-OP) resulted in an increase in the arginine conversion to citrulline, the amount of NOx, the release of amylase, and the level of cGMP. Especially, CCK-OP-stimulated increase of arginine to citrulline transformation, the amount of NOx and cGMP level were completely counteracted by the inhibitor of NOS, NG-monomethyl-L-arginine (MMA), by contrast, that of amylase release was partially reduced. Furthermore, MMA-induced decrease of NOS activity and amylase release showed dose-dependent pattern. The data on the time course of CCK-OP-induced citrulline formation and cGMP rise indicate that NOS and guanylate cyclase were activated by treatment of CCK-OP. However, the mechanism of agonist-stimulated guanylate cyclase activation in acinar cells remains unknown. Therefore, activation of NOS is one of the early events in receptor-mediated cascade of reactions in pancreatic acinar cells and NO, not completely, but partially mediate pancreatic enzyme exocrine secretion.</description><identifier>ISSN: 0253-6269</identifier><identifier>EISSN: 1976-3786</identifier><identifier>DOI: 10.1007/BF02976753</identifier><identifier>PMID: 9868533</identifier><language>eng</language><publisher>Korea (South)</publisher><subject>Amylases - secretion ; Animals ; Cyclic GMP - metabolism ; Cyclic GMP - pharmacology ; Dose-Response Relationship, Drug ; In Vitro Techniques ; Male ; Nitric Oxide - analysis ; Nitric Oxide - antagonists & inhibitors ; Nitric Oxide - physiology ; Nitric Oxide Synthase - analysis ; omega-N-Methylarginine - pharmacology ; Pancreas - secretion ; Rats ; Sincalide - pharmacology ; Time Factors</subject><ispartof>Archives of pharmacal research, 1998-12, Vol.21 (6), p.657-663</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-f00b11c0fd6c452000fc552bace7583b75101f9b643590f17a62e6ac9dc899923</citedby><cites>FETCH-LOGICAL-c282t-f00b11c0fd6c452000fc552bace7583b75101f9b643590f17a62e6ac9dc899923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9868533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahn, S H</creatorcontrib><creatorcontrib>Seo, D W</creatorcontrib><creatorcontrib>Ko, Y K</creatorcontrib><creatorcontrib>Sung, D S</creatorcontrib><creatorcontrib>Bae, G U</creatorcontrib><creatorcontrib>Yoon, J W</creatorcontrib><creatorcontrib>Hong, S Y</creatorcontrib><creatorcontrib>Han, J W</creatorcontrib><creatorcontrib>Lee, H W</creatorcontrib><title>NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells</title><title>Archives of pharmacal research</title><addtitle>Arch Pharm Res</addtitle><description>The enzyme responsible for the synthesis of nitric oxide (NO) from L-arginine in mammalian tissues is known as nitric oxide synthase (NOS) (EC.1.14.13.39). In the present study, the role of NO in the regulation of exocrine secretion was investigated in rat pancreatic acinar cells. Treatment of rat pancreatic acinar cells with cholecystokinin-octapeptide (CCK-OP) resulted in an increase in the arginine conversion to citrulline, the amount of NOx, the release of amylase, and the level of cGMP. Especially, CCK-OP-stimulated increase of arginine to citrulline transformation, the amount of NOx and cGMP level were completely counteracted by the inhibitor of NOS, NG-monomethyl-L-arginine (MMA), by contrast, that of amylase release was partially reduced. Furthermore, MMA-induced decrease of NOS activity and amylase release showed dose-dependent pattern. The data on the time course of CCK-OP-induced citrulline formation and cGMP rise indicate that NOS and guanylate cyclase were activated by treatment of CCK-OP. However, the mechanism of agonist-stimulated guanylate cyclase activation in acinar cells remains unknown. Therefore, activation of NOS is one of the early events in receptor-mediated cascade of reactions in pancreatic acinar cells and NO, not completely, but partially mediate pancreatic enzyme exocrine secretion.</description><subject>Amylases - secretion</subject><subject>Animals</subject><subject>Cyclic GMP - metabolism</subject><subject>Cyclic GMP - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Nitric Oxide - analysis</subject><subject>Nitric Oxide - antagonists & inhibitors</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase - analysis</subject><subject>omega-N-Methylarginine - pharmacology</subject><subject>Pancreas - secretion</subject><subject>Rats</subject><subject>Sincalide - pharmacology</subject><subject>Time Factors</subject><issn>0253-6269</issn><issn>1976-3786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFLAzEQRoMotVYv3oWcPAhrJ0mTbI5abBXUiuh5yWYTjOxuarKt9t-7pUVP8zG8-RgeQucErgmAHN_OgCopJGcHaEj6lDGZi0M0BMpZJqhQx-gkpU8AJjjnAzRQucg5Y0P0-rwYm_nTC17q7uNbb7BP2LfrUK9t1Qdsf4KJvrU4WRNt50OLXQwNjrrrT9p-pztvsDa-1REbW9fpFB05XSd7tp8j9D67e5veZ4-L-cP05jEzNKdd5gBKQgy4SpgJpwDgDOe01MZKnrNScgLEqVJMGFfgiNSCWqGNqkyulKJshC53vcsYvlY2dUXj0_YD3dqwSoVQoCQRvAevdqCJIaVoXbGMvtFxUxAotgKLf4E9fLFvXZWNrf7QvTH2C_vqagk</recordid><startdate>19981201</startdate><enddate>19981201</enddate><creator>Ahn, S H</creator><creator>Seo, D W</creator><creator>Ko, Y K</creator><creator>Sung, D S</creator><creator>Bae, G U</creator><creator>Yoon, J W</creator><creator>Hong, S Y</creator><creator>Han, J W</creator><creator>Lee, H W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981201</creationdate><title>NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells</title><author>Ahn, S H ; Seo, D W ; Ko, Y K ; Sung, D S ; Bae, G U ; Yoon, J W ; Hong, S Y ; Han, J W ; Lee, H W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-f00b11c0fd6c452000fc552bace7583b75101f9b643590f17a62e6ac9dc899923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Amylases - secretion</topic><topic>Animals</topic><topic>Cyclic GMP - metabolism</topic><topic>Cyclic GMP - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Nitric Oxide - analysis</topic><topic>Nitric Oxide - antagonists & inhibitors</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase - analysis</topic><topic>omega-N-Methylarginine - pharmacology</topic><topic>Pancreas - secretion</topic><topic>Rats</topic><topic>Sincalide - pharmacology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahn, S H</creatorcontrib><creatorcontrib>Seo, D W</creatorcontrib><creatorcontrib>Ko, Y K</creatorcontrib><creatorcontrib>Sung, D S</creatorcontrib><creatorcontrib>Bae, G U</creatorcontrib><creatorcontrib>Yoon, J W</creatorcontrib><creatorcontrib>Hong, S Y</creatorcontrib><creatorcontrib>Han, J W</creatorcontrib><creatorcontrib>Lee, H W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of pharmacal research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahn, S H</au><au>Seo, D W</au><au>Ko, Y K</au><au>Sung, D S</au><au>Bae, G U</au><au>Yoon, J W</au><au>Hong, S Y</au><au>Han, J W</au><au>Lee, H W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells</atitle><jtitle>Archives of pharmacal research</jtitle><addtitle>Arch Pharm Res</addtitle><date>1998-12-01</date><risdate>1998</risdate><volume>21</volume><issue>6</issue><spage>657</spage><epage>663</epage><pages>657-663</pages><issn>0253-6269</issn><eissn>1976-3786</eissn><abstract>The enzyme responsible for the synthesis of nitric oxide (NO) from L-arginine in mammalian tissues is known as nitric oxide synthase (NOS) (EC.1.14.13.39). In the present study, the role of NO in the regulation of exocrine secretion was investigated in rat pancreatic acinar cells. Treatment of rat pancreatic acinar cells with cholecystokinin-octapeptide (CCK-OP) resulted in an increase in the arginine conversion to citrulline, the amount of NOx, the release of amylase, and the level of cGMP. Especially, CCK-OP-stimulated increase of arginine to citrulline transformation, the amount of NOx and cGMP level were completely counteracted by the inhibitor of NOS, NG-monomethyl-L-arginine (MMA), by contrast, that of amylase release was partially reduced. Furthermore, MMA-induced decrease of NOS activity and amylase release showed dose-dependent pattern. The data on the time course of CCK-OP-induced citrulline formation and cGMP rise indicate that NOS and guanylate cyclase were activated by treatment of CCK-OP. However, the mechanism of agonist-stimulated guanylate cyclase activation in acinar cells remains unknown. Therefore, activation of NOS is one of the early events in receptor-mediated cascade of reactions in pancreatic acinar cells and NO, not completely, but partially mediate pancreatic enzyme exocrine secretion.</abstract><cop>Korea (South)</cop><pmid>9868533</pmid><doi>10.1007/BF02976753</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0253-6269 |
ispartof | Archives of pharmacal research, 1998-12, Vol.21 (6), p.657-663 |
issn | 0253-6269 1976-3786 |
language | eng |
recordid | cdi_proquest_miscellaneous_69097165 |
source | MEDLINE; SpringerLink Journals |
subjects | Amylases - secretion Animals Cyclic GMP - metabolism Cyclic GMP - pharmacology Dose-Response Relationship, Drug In Vitro Techniques Male Nitric Oxide - analysis Nitric Oxide - antagonists & inhibitors Nitric Oxide - physiology Nitric Oxide Synthase - analysis omega-N-Methylarginine - pharmacology Pancreas - secretion Rats Sincalide - pharmacology Time Factors |
title | NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A58%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NO/cGMP%20pathway%20is%20involved%20in%20exocrine%20secretion%20from%20rat%20pancreatic%20acinar%20cells&rft.jtitle=Archives%20of%20pharmacal%20research&rft.au=Ahn,%20S%20H&rft.date=1998-12-01&rft.volume=21&rft.issue=6&rft.spage=657&rft.epage=663&rft.pages=657-663&rft.issn=0253-6269&rft.eissn=1976-3786&rft_id=info:doi/10.1007/BF02976753&rft_dat=%3Cproquest_cross%3E69097165%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69097165&rft_id=info:pmid/9868533&rfr_iscdi=true |